PHARMOZYME, INC. – Trademark Portfolio

Entity Type: 03

PHARMOZYME, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 1 is pending. The owner is based in Sunnyvale, CA.

1190 Mountain View Alviso Rd Ste H

Sunnyvale, CA 94089

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PHARMOZYME, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does PHARMOZYME, INC. have?

PHARMOZYME, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 pending, 3 abandoned.

What trademark classes does PHARMOZYME, INC. file in?

PHARMOZYME, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is PHARMOZYME, INC.'s trademark registration success rate?

PHARMOZYME, INC. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.